Delivery Order SPE2DR25D1053-SPE2DR26FT877
- Not listed
- The Defense Logistics Agency awarded a $2,305.26 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Naftifine HCL 2% Gel in 60-gram quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,939.04 to AmerisourceBergen Drug Corp for Naftifine HCL 2% Gel in 45-gram units. This competitively awarded, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,127.35 to AmerisourceBergen Drug Corp for the supply of Naftifine HCL 2% Gel in 60-gram quantities. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of November 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Naftifine HCL 2% Gel in 60-gram quantities, with a ceiling value of $1,073.57. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Naftifine HCL 2% Cream in 60-gram quantities, with a ceiling value of $8,129.88 and completion targeted for October 15, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram units, valued at $2,502.11. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract was executed with an ultimate completion date of September 4, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,941.77 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram units. This firm fixed price, non-set-aside contract is scheduled for completion by August 27, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,961.53 to AmerisourceBergen Drug Corp for Naftifine HCL 1% Cream in 60-gram units. This firm fixed-price contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside delivery order under DLA's pharmaceutical supply chain. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naftifine HCL 1% Cream in 60-gram quantities, with a ceiling value of $2,146.02. The contract is firm fixed price with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 12, 2025. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $1,364.53 delivery order to AmerisourceBergen Drug Corp for Naftifine HCL 2% Gel 60GM, a topical antifungal medication. This firm fixed price, non-set-aside contract is scheduled for completion by September 5, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT877Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Naftifine HCL 2% Gel in 60-gram units, with a ceiling value of $2,343.43. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The contract is scheduled for completion by November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement extending through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, regularly supplies the federal government with a broad range of medications and medical products through its extensive partnership with the Defense Logistics Agency. The company's federal contracting portfolio demonstrates consistent capability in fulfilling competitive awards across multiple therapeutic domains, including specialty medications, generic drugs, and medical devices. This naftifine order represents a routine pharmaceutical procurement supporting military and defense healthcare operations. The DLA Troop Support Medical contract vehicle under which this delivery order was issued represents a critical infrastructure for ensuring reliable pharmaceutical supply chains to defense health systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/13/25 |